Login

Our Newsletter

Meet the Scientist – Dr. Fawaz Alzaid

Our Newsletter

DR. FAWAZ ALZAID Meet the scientists behind DDI’s research DR. FAWAZ ALZAID has a PhD in Human Nutrition from King’s College London, where his studies were focused on glucose intestina ...

New Immunophenotypic Profiling helps identifying T2D patients at risk of severe COVID-19

Our Newsletter

This study was a collaboration between Sorbonne Université and the Public Hospitals of Paris (Assistance Publique – Hôpitaux de Paris, AP-HP). It investigated the characteristics of immune cells ...

DDI announces the establishment of a new research department: Bioenergetics

Our Newsletter

This new department is led by Dr. Fawaz Alzaid. In this segment, we highlight the future plan for the Bioenergetics Department at DDI. Energy imbalance affects the body’s metabolism in various w ...

DDI researchers delivered two oral presentations and 12 abstracts in the ADA 82nd scientific sessions

Our Newsletter

DDI research departments have contributed immensely this year by presenting the research conducted in Kuwait at one of the most recognized diabetes conferences in the world: the American Diabetes Ass ...

Meet the Scientist – Dr. Mohammed Dashti

Our Newsletter

DR. MOHAMMED DASHTI Meet the scientists behind DDI’s research DR. MOHAMMED DASHTI has a PhD in Genetics, Genomics, and System medicine (Geneticsand Bioinformatics). He received his train ...

Can Behavioral and Environmental Factors Influence Gene Activity and Cause Type 1 Diabetes?

Our Newsletter

Recently, there has been a growing interest in examining the role of heritable changes caused by gene activation or deactivation in type 1 diabetes (T1D) development, primarily through processes ...

GLOBAL COLLABORATIVE APPROACH IN DISCOVERING GENETIC DETERMINANTS OF METABOLIC DISORDERS

Our Newsletter

There is currently a global effort to apply large-scale genomic science and associated technologies to further the understanding of disease pathogenesis in diverse populations. These efforts focus on ...

Research During 2021 in a Glance

Our Newsletter

Number and Impact factor of DDI’s published articles from 2016 until 2021. Here we highlight insightful published work in the department of Genetics and Bioinformatics: MMP9 is a molecule ...

Meet The Scientist – Sarah Qabazard

Our Newsletter

SARAH QABAZARD Meet the scientists behind DDI’s research SARAH QABAZARD is graduated with a BSc in Nutrition from the University of Hertfordshire and a MSc in Clinical and Public Health N ...

Scientists at DDI discover a new Branch in the regulation of IL-6 in Fat cells

Our Newsletter

Kuwait is amongst top-ranking nations afflicted badly by obesity epidemic and its wide-scale complications such as increased blood pressure, heart disease, stroke, digestive problems, certain cancers ...

Meet the Scientist – Maha Hammad

Our Newsletter

MAHA HAMMAD graduated from Kuwait University with a BSc in Biochemistry and Molecular Biology (Distinction with Class Honours). She pursued her graduate studies in Canada.

Scientists at DDI discover a mutation in the kuwaiti population that causes obesity

Our Newsletter

The Leptin-Melanocortin pathway is an important system in the regulation of food intake and energy expenditure. It is unique because it can integrate neural, metabolic, and hormonal signals. One k ...

DDI announces the official establishment of PORTAL or the Public Office for Research Translation and Liaison

Our Newsletter

PORTAL was decreed in 2019 by DG Dr. Qais Al-Duwairi to educate and engage the public sector in the research performed and scientific breakthroughs established at DDI. Education is necessary to i ...

DDI announces the establishment of PCR-Q8 or the pediatric Covid-19 registry in Kuwait

Our Newsletter

PCR-Q8 is a collaborative project between the Ministry of Health and DDI. “Establishing a pediatric COVID-19 registry in Kuwait was deemed imperative during the pandemic to assess children i ...

Biochemistry and Molecular Biology Unit are granted a patent

Our Newsletter

The DDI “Patent and Research Translation Committee” congratulates the researchers on the grant of U.S. patent on our new invention “Use of MicroRNA-103 as Inhibitor for dyslipidemia by rep ...

Would you like to subscribe
to our newsletter?